Back to Results

Artivion Inc (AORT)

Artivion, Inc. is a healthcare equipment and supplies company focused on medical devices and implantable human tissues used in cardiovascular and aortic care. Its product portfolio includes On-X prosthetic heart valves, aortic prostheses, hybrid stent graft systems, endovascular stent grafts, synthetic vascular grafts, and surgical sealants, along with related preservation and processing services. The company also offers technologies and products such as BioGlue, CryoValve SG, CryoPatch SG, SynerGraft, and PhotoFix, and provides pyrolytic carbon coating services. Artivion markets its products and services primarily through a direct sales organization to physicians, hospitals, and other healthcare facilities worldwide. Formerly known as CryoLife, Inc., the company adopted the Artivion name in January 2022 and was incorporated in 1984. It is headquartered in Kennesaw, Georgia, and its common stock is listed on the NYSE under the ticker AORT.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-AORT
$20.66
-18.4% Downside
Overvalued
$40.91
61.5% Upside
Bargain
Good
0.0%
2.8x
2.6x
1.235 B
1.566 B
24.0%
94.9%
2.9
287.0%
Valuation • Fair Value

Artivion Inc (NYSE-AORT) Fair Value by Valuation Model

Review the available estimates for Artivion Inc (NYSE-AORT), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$20.66

Estimated downside of 18.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$21.88

Discounted cash flow valuation reference.

Comps Fair Value

$19.43

Comparable-company valuation reference.

Analyst Price Target

$40.91

Analysts imply upside of 61.5%.

How to read these valuation models

Use the 5 available valuation references for Artivion Inc (NYSE-AORT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Artivion Inc (NYSE-AORT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

471.5 M

Current operating scale indicator.

Revenue Forecast

492.4 M

Forward revenue estimate.

EBITDA

63.715 M

Current operating profitability reference.

EBITDA Forecast

94.85 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Artivion Inc (NYSE-AORT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Artivion Inc (NYSE-AORT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.62

No elevated caution signal from this screen.

Altman Z-Score

2.9

Intermediate risk zone.

FCF / Net Income

287.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Artivion Inc (NYSE-AORT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Artivion Inc (NYSE-AORT)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Artivion Inc (NYSE-AORT). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Artivion Inc (NYSE-AORT) Stock Forecast & Technical Outlook

Review Artivion Inc (NYSE-AORT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Artivion Inc (NYSE-AORT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Artivion Inc (NYSE-AORT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Artivion Inc (NYSE-AORT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Artivion Inc (NYSE-AORT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Artivion Inc (NYSE-AORT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Artivion Inc (NYSE-AORT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Artivion Inc (NYSE-AORT) has a Strong Buy consensus, with 7 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 7
Hold 0
Sell 0
FAQ • Fast Investor Answers

Artivion Inc (NYSE-AORT) Stock FAQ

Data-supported answers about Artivion Inc (NYSE-AORT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$20.66
Estimated downside 18.4%
Valuation Rating
Overvalued
Estimated downside of 18.4%
Analyst Target
$40.91
Implied upside 61.5%
Financial Health
Good
Current financial-health read

The current fair value estimate for Artivion Inc (NYSE-AORT) is $20.66. This implies an estimated downside of 18.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 18.4% versus the current market price.

The available analyst price target for Artivion Inc (NYSE-AORT) is $40.91. The analyst target implies estimated upside of 61.5%.

The current financial health read for Artivion Inc (NYSE-AORT) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Artivion Inc (NYSE-AORT).

The current market capitalization listed for Artivion Inc is 1.235 B.

The current enterprise value listed for Artivion Inc is 1.566 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Artivion Inc is NYSE-AORT, and the stock is listed on NYSE.

Artivion Inc (NYSE-AORT) is listed on NYSE.

The current debt-to-total-capital ratio listed for Artivion Inc is 24.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Artivion Inc is 94.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 196.7 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 162.4 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 128.3 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 127.6 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 64.704 B
BDX NYSE Becton Dickinson and Co Fair Value Fair Market Cap 58.168 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 57.971 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 52.86 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 52.302 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Fair Market Cap 37.867 B
ALC NYSE Alcon AG Fair Value Fair Market Cap 37.14 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 33.661 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 31.503 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 30.181 B
STE NYSE STERIS plc Fair Value Fair Market Cap 24.777 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 20.222 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.84 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 13.319 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.27 B
GKOS NYSE Glaukos Corp Fair Value Overvalued Market Cap 13.016 B